1R2H image
Deposition Date 2003-09-26
Release Date 2004-02-03
Last Version Date 2023-08-23
Entry Detail
PDB ID:
1R2H
Keywords:
Title:
Human Bcl-XL containing an Ala to Leu mutation at position 142
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.23
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 41 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Apoptosis regulator Bcl-X
Gene (Uniprot):BCL2L1
Mutagens:A142L
Chain IDs:A
Chain Length:218
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Bcl-XL mutations suppress cellular sensitivity to antimycin A.
J.Biol.Chem. 279 2159 2165 (2004)
PMID: 14534311 DOI: 10.1074/jbc.M306021200

Abstact

Cells expressing high levels of the BCL-X(L) anti-apoptotic protein are preferentially killed by the mitochondrial inhibitor antimycin A (AA). Computational modeling predicts a binding site for AA in the extended hydrophobic groove on BCL-X(L), previously identified as an interface for dimerization to BAX and related proapoptotic proteins. Here, we identify BCL-X(L) hydrophobic groove mutants with normal cellular anti-apoptotic function but suppressed sensitivity to AA. The LD(50) of AA for cells expressing BCL-X(L) mutants directly correlates with the measured in vitro dissociation constants for AA binding. These results indicate that BCL-X(L) is a principal target mediating AA cytotoxicity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures